MaxCyte, Inc. (MXCT) Shareholders’ equity 2019–2025
MaxCyte, Inc. (MXCT) shareholders’ equity at each fiscal year-end, per SEC filings.
$171.5MFY2025 · since FY2019: $13.6M → $171.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $171.5M | -16.9% |
| FY2024 | $206.3M | -11.2% |
| FY2023 | $232.2M | -8.6% |
| FY2022 | $254.0M | -3.4% |
| FY2021 | $262.9M | +691.3% |
| FY2020 | $33.2M | +144.3% |
| FY2019 | $13.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice